Text Size

Prostate Cancer Nomograms : Disclaimer

The prediction tools, also known as prognostic nomograms, located on the MSKCC Web site are for general health information only. The prediction tools are not to be used as a substitute for medical advice, diagnosis, or treatment of any health condition or problem.

Users of the prediction tools should not rely on information provided by the prediction tools for their own health problems. Questions should be addressed to your own physician or other healthcare provider.

MSKCC makes no warranties, nor express or implied representations whatsoever, regarding the accuracy, completeness, timeliness, comparative or controversial nature, or usefulness of any information contained or referenced in the prediction tools. MSKCC does not assume any risk whatsoever for your use of the prediction tools or the information contained herein. Health related information changes frequently and therefore information contained in the prediction tools may be outdated, incomplete or incorrect.

Use of the prediction tools does not create an express or implied physician-patient relationship. MSKCC does not endorse or claim validity for the prediction tools found on the MSKCC Web site. The activities and products of MSKCC and its developers and agents (collectively MSKCC) are not endorsed by our past, present, or future employers. MSKCC does not record specific prediction tool user information and does not contact users of the prediction tools.

You are hereby advised to consult with a physician or other professional healthcare provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any healthcare problem or issue you might have at any time, now or in the future. In using the prediction tools, you agree that neither MSKCC nor any other party is or will be liable or otherwise responsible for any decision made or any action taken or any action not taken due to your use of any information presented in the prediction tools.

I accept all of the above terms by clicking here or by any further use of this service.
I do not accept all of the above terms.

Prostate Cancer Nomograms: Post-Radical Prostatectomy

This nomogram can be used to predict the probability that a patient's cancer will recur after radical prostatectomy, that is, the probability at two, five, seven and 10 years that the patient's serum PSA level will become detectable and begin to rise steadily. The nomogram should only be used for patients when radical prostatectomy is the sole, primary treatment. To learn more, visit our frequently asked questions.

CalculateClearEnter Your Information

PSA value from the laboratory report before the radical prostatectomy was performed or any other therapy for prostate cancer begun.
(0.1 to 100 ng/ml)
(20 to 120 yrs)

Gleason Grade

The primary Gleason grade from the radical prostatectomy pathology report.
The secondary Gleason grade from the radical prostatectomy pathology report.
Gleason sum will be automatically calculated or can be added here if the primary and secondary Gleason grades are not known.

Prostatectomy Pathology Report Details

Was cancer present at edges of removed prostate?
Was there extra capsular extension?
Was cancer present in seminal vesicles?
Was cancer present in pelvic lymph nodes?
Treated with hormone therapy prior to radical prostatectomy?
Treated with radiation therapy prior to radical prostatectomy?

Your Results

Progression-Free Probability After Surgery 2 Year
5 Year
7 Year
10 Year
Make an Appointment Call us to schedule an appointment or contact us online Contact Us

Learn More About Your Results

Progression-Free Probability After Surgery

In the current model, this tool predicts the two, five, seven, and 10 year probability that a prostate cancer will not progress after radical prostatectomy -- i.e., that the PSA will remain undetectable with no other therapy other than radical prostatectomy. The historical model allows the entry of more detailed information about prostate capsule invasion and provides two, five, and seven year probability that the cancer will not progress based on a cohort of patients treated between 1983 and 1995.

For an explanation of the difference between the Current and Historical models, visit www.mskcc.org/mskcc/html/89996.cfm#443360.

Supporting Publication

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005 Oct 1;23(28):7005-12.
Postoperative Nomogram for Disease Recurrence after Radical Prostatectomy for Prostate Cancer. Journal of Clinical Oncology 1999; 17:1499-1507.